by Stacey Johnson | Oct 20, 2017
In what feels like back-to-back news, the U.S. Food and Drug Administration (FDA) has approved two gene therapies for cancer. The actual announcements happened seven weeks apart, but for patients, manufacturers, investors and shareholders, it’s like Christmas – over...
by Stacey Johnson | Oct 13, 2017
If you’ve stumbled upon this blog thinking you will be reading about the attractive and talented cast of the popular 2016 TV show on NBC, I suspect you will be very disappointed. While there is video for you below, you will not see any rippling muscles and you don’t...
by Stacey Johnson | Aug 9, 2017
Although new to the field of science communication, Nathan Holwell has been involved in a variety of research during his undergraduate career and now in his graduate career. He has done research in drug delivery, gene delivery, biomaterials and diagnostic devices. His...
by Hamideh Emrani | Jul 20, 2017
Passing by university campuses in the month of June, what you will notice is joyful, well dressed students, accompanied by family members, attending their graduation ceremonies. It is indeed a great feeling to have accomplished a university degree after a lot of...
by Stacey Johnson | Jun 16, 2017
Understanding cell therapy regulation is an essential component of the bench to bedside pipeline. Without approval from a country’s regulator (Health Canada, FDA, EMA, PMDA, etc.), a product cannot be sold to consumers and the millions invested in research and...
by Stacey Johnson | Jun 2, 2017
It has been said that the pen is mightier than the sword. Where, then, does the gun factor in? I was amazed, last year, when I learned of the “biopen,” a medical device that draws stem cells to repair damaged or worn cartilage and then the cartilage heals itself with...
Comments